Published in Acta Psychiatr Scand on June 01, 1988
Involvement of BDNF in age-dependent alterations in the hippocampus. Front Aging Neurosci (2010) 0.98
Parkinson's disease as a result of aging. Aging Cell (2015) 0.92
Pharmacological stimulation of locus coeruleus reveals a new antipsychotic-responsive pathway for deficient sensorimotor gating. Neuropsychopharmacology (2011) 0.86
The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology (Berl) (1993) 0.84
Early neurone loss in Alzheimer's disease: cortical or subcortical? Acta Neuropathol Commun (2015) 0.83
The Locus Coeruleus: Essential for Maintaining Cognitive Function and the Aging Brain. Trends Cogn Sci (2016) 0.83
Why patients with Alzheimer's disease may show increased sensitivity to tropicamide eye drops: role of locus coeruleus. Psychopharmacology (Berl) (2005) 0.83
Parallel declines in cognition, motivation, and locomotion in aging mice: association with immune gene upregulation in the medial prefrontal cortex. Exp Gerontol (2011) 0.82
Age-associated changes in mRNA levels of Phox2, norepinephrine transporter and dopamine beta-hydroxylase in the locus coeruleus and adrenal glands of rats. J Neurochem (2005) 0.80
Neuromelanin marks the spot: identifying a locus coeruleus biomarker of cognitive reserve in healthy aging. Neurobiol Aging (2015) 0.77
Atomoxetine accelerates attentional set shifting without affecting learning rate in the rat. Psychopharmacology (Berl) (2015) 0.76
Diminished serum repetin levels in patients with schizophrenia and bipolar disorder. Sci Rep (2015) 0.75
In vivo visualization of the locus coeruleus in humans: quantifying the test-retest reliability. Brain Struct Funct (2017) 0.75
UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull (2001) 5.89
Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology (2003) 3.07
Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry (2001) 2.95
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74
Late-onset schizophrenia: an overview. Schizophr Bull (1988) 2.58
Social skills performance assessment among older patients with schizophrenia. Schizophr Res (2001) 2.53
Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry (2000) 2.19
Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry (2000) 2.04
Enhancing informed consent for research and treatment. Neuropsychopharmacology (2001) 2.04
Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology (1997) 2.01
Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology (2000) 1.91
Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Arch Gen Psychiatry (1995) 1.88
Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry (1999) 1.86
Depressive symptoms in schizophrenia. Am J Psychiatry (1999) 1.83
Cognitive training in Alzheimer's disease: a meta-analysis of the literature. Acta Psychiatr Scand (2006) 1.75
Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry (1989) 1.69
Schizophrenia in homeless persons: a systematic review of the literature. Acta Psychiatr Scand (2002) 1.63
New-onset psychosis in HIV-infected patients. J Clin Psychiatry (1991) 1.62
Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. Arch Gen Psychiatry (1994) 1.55
Physical comorbidity and polypharmacy in older psychiatric patients. Biol Psychiatry (1994) 1.54
Gender-related clinical differences in older patients with schizophrenia. J Clin Psychiatry (1999) 1.49
Psychotic symptoms in Parkinson's disease patients with dementia. J Am Geriatr Soc (1996) 1.46
The potential impact of the baby-boom generation on substance abuse among elderly persons. Psychiatr Serv (1999) 1.45
Late-onset psychosis with somatic delusions. Psychosomatics (1994) 1.45
Geriatric psychiatry may be the mainstream psychiatry of the future. Am J Psychiatry (2000) 1.40
Late-onset psychosis: clinical, research, and ethical considerations. Am J Psychiatry (1999) 1.37
The nature of learning and memory impairments in schizophrenia. J Int Neuropsychol Soc (1995) 1.31
Psychophysiologic therapy based on the concepts of Patanjail. A new approach to the treatment of neurotic and psychosomatic disorders. Am J Psychother (1973) 1.28
Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol (1998) 1.22
Use of oral reading to estimate premorbid intellectual and neuropsychological functioning. J Int Neuropsychol Soc (1999) 1.18
Enhancing comprehension of consent for research in older patients with psychosis: a randomized study of a novel consent procedure. Am J Psychiatry (2001) 1.16
Schizoaffective disorder: a form of schizophrenia or affective disorder? J Clin Psychiatry (1999) 1.13
Did schizophrenia exist before the eighteenth century? Compr Psychiatry (1986) 1.11
Association of depressive symptoms with worse functioning in schizophrenia: a study in older outpatients. J Clin Psychiatry (2001) 1.08
Parkinsonism in neuroleptic-naive schizophrenic patients. Am J Psychiatry (1993) 1.07
Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype. Mol Psychiatry (2003) 1.07
Reduced Purkinje cell density in Huntington's disease. Exp Neurol (1984) 1.06
Self-reported social functioning among older patients with schizophrenia. Schizophr Res (1997) 1.02
The first Summer Research Institute in Geriatric Psychiatry. Am J Geriatr Psychiatry (1997) 1.01
Incidence and risk factors for severe tardive dyskinesia in older patients. Br J Psychiatry (1997) 1.00
Treatment costs and use of community mental health services for schizophrenia by age cohorts. Am J Psychiatry (1996) 0.98
Older patients with schizophrenia: challenges in the coming decades. Psychiatr Serv (1999) 0.98
Cross-sectional study of older outpatients with schizophrenia and healthy comparison subjects: no differences in age-related cognitive decline. Am J Psychiatry (2000) 0.98
Correlates of functional status in older patients with schizophrenia. Psychiatry Res (1998) 0.98
Gender, estrogen, and schizophrenia. Psychopharmacol Bull (1997) 0.97
Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients. Schizophr Res (2001) 0.96
Impairment of the semantic network in schizophrenia. Psychiatry Res (1996) 0.95
Quality of well-being in late-life psychosis. Psychiatry Res (1996) 0.95
Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry (2000) 0.95
Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. Am J Psychiatry (1995) 0.93
Changing epidemiology of tardive dyskinesia: an overview. Am J Psychiatry (1981) 0.93
Tardive dyskinesia--reversible and persistent. Arch Gen Psychiatry (1979) 0.93
Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull (1992) 0.93
Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients. Psychiatry Res (2001) 0.93
Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. Schizophr Bull (1988) 0.93
A comparison of community-dwelling older schizophrenia patients by residential status. Acta Psychiatr Scand (2001) 0.92
Decision-making capacity for informed consent in the older population. Bull Am Acad Psychiatry Law (1995) 0.92
HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group. Am J Psychiatry (1994) 0.92
Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations. Drugs Aging (2000) 0.91
Multivariate predictors of social skills performance in middle-aged and older out-patients with schizophrenia spectrum disorders. Psychol Med (2007) 0.91
A randomized controlled pilot study of cognitive behavioral social skills training for older patients with schizophrenia. Schizophr Res (2002) 0.91
Accelerated age-related decline in processing resources in schizophrenia: evidence from pupillary responses recorded during the span of apprehension task. J Int Neuropsychol Soc (2000) 0.91
Direct assessment of functional status in older patients with schizophrenia. Am J Psychiatry (1997) 0.90
Development of an integrated cognitive-behavioral and social skills training intervention for older patients with schizophrenia. J Psychother Pract Res (2000) 0.90
Alzheimer's disease and its management in the year 2010. Psychiatr Serv (1999) 0.90
Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics. J Clin Psychopharmacol (1999) 0.90
Pupillary responses index overload of working memory resources in schizophrenia. J Abnorm Psychol (1997) 0.89
Neurobehaviors and psychotic symptoms in Alzheimer's disease. J Int Neuropsychol Soc (2000) 0.89
Sleep-disordered breathing and periodic limb movements in sleep in older patients with schizophrenia. Biol Psychiatry (1999) 0.89
Cognitive deficits and psychopathology in institutionalized versus community-dwelling elderly schizophrenia patients. J Geriatr Psychiatry Neurol (1999) 0.89
Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases. J Neuropsychiatry Clin Neurosci (1992) 0.88
Voluntary movement dysfunction in Huntington's disease and tardive dyskinesia. Acta Neurol Scand (1987) 0.88
Antipsychotics. Clin Geriatr Med (1990) 0.87
Geriatric psychosis. Psychiatr Q (1997) 0.87
Biological research in geriatric psychiatry. Biol Psychiatry (1991) 0.87
Serendipity in biological psychiatry--a myth? Arch Gen Psychiatry (1979) 0.87
Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: comparison of matched groups with autopsy-confirmed diagnoses. Int J Geriatr Psychiatry (2000) 0.86
Therapeutic strategies against tardive dyskinesia. Two decades of experience. Arch Gen Psychiatry (1982) 0.85
Neurobehavioral and neurodiagnostic aspects of late-onset psychosis. Arch Clin Neuropsychol (1994) 0.84
Cerebellar pathology in schizophrenia? A neuronometric study. Biol Psychiatry (1986) 0.84
Review of functional magnetic resonance imaging in schizophrenia. Schizophr Res (1997) 0.83
Sensory impairment in late-life schizophrenia. Schizophr Bull (1993) 0.83
Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiatry (1990) 0.83
Anxiety disorders in the elderly: DSM-IV and other barriers to diagnosis and treatment. J Affect Disord (1997) 0.83
Hippocampal pyramidal cells and aging in the human: a quantitative study of neuronal loss in sectors CA1 to CA4. Exp Neurol (1986) 0.83
Training in geriatric mental health: needs and strategies. Psychiatr Serv (1999) 0.82
A clinical and neuropsychological comparison of delusional disorder and schizophrenia. J Neuropsychiatry Clin Neurosci (1996) 0.82
Schizophrenia in late life: findings challenge traditional concepts. Harv Rev Psychiatry (2001) 0.82
Low dose bromocriptine: a study of acute effects in chronic mediated schizophrenics. Prog Neuropsychopharmacol Biol Psychiatry (1984) 0.82
Personality profiles among normal aged individuals as measured by the NEO-PI-R. Aging Ment Health (2001) 0.82
N400 abnormalities in late life schizophrenia and related psychoses. Biol Psychiatry (1997) 0.81
Metoclopramide and tardive dyskinesia. Biol Psychiatry (1994) 0.81
Late life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients. Clin Geriatr Med (1992) 0.81
Health-related quality of life in older patients with schizophrenia and other psychoses: relationships among psychosocial and psychiatric factors. Int J Geriatr Psychiatry (1997) 0.80
Unrecognised cognitive impairment in hospice patients: a pilot study. Palliat Med (2008) 0.80
Lack of clinically significant gross structural abnormalities in MRIs of older patients with schizophrenia and related psychoses. J Neuropsychiatry Clin Neurosci (1997) 0.80
Neuroleptics and alternative treatments. Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions. Psychiatr Clin North Am (1988) 0.80
Citalopram augmentation of antipsychotic treatment in older schizophrenia patients. Int J Geriatr Psychiatry (2001) 0.80
Relationship between auditory P300 amplitude and age of onset of schizophrenia in older patients. Psychiatry Res (1998) 0.80
Preliminary report: cerebral blood flow abnormalities in older schizophrenic patients. Psychiatry Res (1994) 0.80